Weiyun Wu

Weiyun Wu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2013 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
WWWeiyun Wu
Weiyun Wu
JYJingfang Yang
Jingfang Yang
XFXiao Feng
Xiao Feng
HWHao Wang
Hao Wang
SYShicai Ye
Shicai Ye
YZYu Zhou
Yu Zhou
Background: Colorectal carcinoma (CRC) is one of the leading causes of cancer-related mortality worldwide. MicroRNAs (miRNAs, miRs) play important roles in carcinogenesis. MiR-32 has been shown to be upregulated in CRC. In this study, we identified the potential effects of miR-32 on some important biological properties of CRC cells, and clarified the regulation of PTEN by miR-32. Methods: The effect of miR-32 on PTEN expression was assessed in CRC cell lines with miR-32 mimics/inhibitor to increase/decrease miR-32 expression. Furthermore, the roles of miR-32 in regulating CRC cells biological properties were analyzed with miR-32 mimics/inhibitor-transfected cells. The 3′-untranslated region (3′-UTR) of PTEN combined with miR-32 was verified by dual-luciferase reporter assay. Results: Gain-of-function and loss-of-function studies showed that overexpression of miR-32 promoted SW480 cell proliferation, migration, and invasion, reduced apoptosis, and resulted in downregulation of PTEN at a posttranscriptional level. However, miR-32 knock-down inhibited these processes in HCT-116 cells and enhanced the expression of PTEN protein. In addition, we further identified PTEN as the functional downstream target of miR-32 by directly targeting the 3′-UTR of PTEN. Conclusions: Our results demonstrated that miR-32 was involved in tumorigenesis of CRC at least in part by suppression of PTEN.

17 December 2013 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
WWWeiyun Wu
Weiyun Wu
ZWZhuang Wang
Zhuang Wang
PYPengchun Yang
Pengchun Yang
JYJingfang Yang
Jingfang Yang
JLJian Liang
Jian Liang
YZYu Zhou
Yu Zhou

7 October 2013 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
WWWeiyun Wu
Weiyun Wu
PYPengchun Yang
Pengchun Yang
XFXiao Feng
Xiao Feng
HWHao Wang
Hao Wang
YQYumei Qiu
Yumei Qiu
YZYu Zhou
Yu Zhou

1 January 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
TRTianhua Ren
Tianhua Ren
YQYumei Qiu
Yumei Qiu
WWWeiyun Wu
Weiyun Wu
FXFeng Xiao
Feng Xiao
SYShicai Ye
Shicai Ye
YZYu Zhou
Yu Zhou
To investigate the expression of adenosine A3 receptor (A3AR) in human colonic epithelial cells and the effects of A3AR activation on tumor necrosis factor alpha (TNF-α-) induced inflammation in order to determine its mechanism of action in human colonic epithelial cells, human colonic epithelial cells (HT-29 cells) were treated with different concentrations of 2-Cl-IB-MECA prior to TNF-αstimulation, followed by analysis of NF-κB signaling pathway activation and downstream IL-8 and IL-1βproduction. A3AR mRNA and protein were expressed in HT-29 cells and not altered by changes in TNF-αor 2-Cl-IB-MECA. Pretreatment with 2-Cl-IB-MECA prior to stimulation with TNF-αattenuated NF-κB p65 nuclear translocation as p65 protein decreased in the nucleus of cells and increased in the cytoplasm, inhibited the degradation of IκB-α, and reduced phosphorylated-IκB-αlevel significantly, compared to TNF-α-only-treated groups. Furthermore, 2-Cl-IB-MECA significantly decreased TNF-α-stimulated IL-8 and IL-1βmRNA expression and secretion, compared to the TNF-α-only treated group. These results confirm that A3AR is expressed in human colonic epithelial cells and demonstrate that its activation has an anti-inflammatory effect, through the inhibition of NF-κB signaling pathway, which leads to inhibition of downstream IL-8 and IL-1βexpression. Therefore, A3AR activation may be a potential treatment for gut inflammatory diseases such as inflammatory bowel disease.

19 May 2021 in Nanomedicine
Verified
Journal Article
Closed access
JQJuan-Hua Quan
Juan-Hua Quan
FGFei Fei Gao
Fei Fei Gao
JCJiaqi Chu
Jiaqi Chu
GCGuang-Ho Cha
Guang-Ho Cha
JYJae-Min Yuk
Jae-Min Yuk
YLYoung-Ha Lee
Young-Ha Lee
Aim: To investigate the anticancer mechanisms of silver nanoparticles (AgNPs) in colorectal cancer. Methods: Anticancer effects of AgNPs were determined in colorectal cancer HCT116 cells and xenogr...

22 March 2021 in Oncology Letters
Verified
Journal Article
Open access
PDF file
WWWeiyun Wu
Weiyun Wu
YCYongze Chen
Yongze Chen
SYShicai Ye
Shicai Ye
HYHui Yang
Hui Yang
JYJianyun Yang
Jianyun Yang
JQJuan-Hua Quan
Juan-Hua Quan
Increased microRNA (miR)‑32 expression in colorectal cancer (CRC) tissues enhances CRC cell proliferation, migration, invasion and attenuates CRC cell apoptosis by repressing the expression of phosphatase and tensin homolog (PTEN). Forkhead box K1 (FOXK1) was identified as a potential interacting transcription factor using DNA pull‑down assays and mass spectrometry. The present study aimed to elucidate the role of FOXK1 in regulating miR‑32 expression in CRC. The expressions of FOXK1, miR‑32, transmembrane protein 245 gene (TMEM245) and PTEN were compared between CRC and normal colonic tissues. Levels of miR‑32, TMEM245, PTEN and the proliferation and apoptosis of CRC cells were studied using FOXK1‑overexpression or knockdown, or by simultaneously interfering with FOXK1 and miR‑32 expression. Direct FOXK1 binding to the miR‑32 promoter was verified using chromatin immunoprecipitation (ChIP) and dual‑luciferase reporter assays. The results showed elevated FOXK1, miR‑32 and TMEM245 expression, and significantly decreased PTEN expression in CRC, compared with normal colonic tissues. Correlations between the expressions of TMEM245 and miR‑32, FOXK1 and miR‑32, and FOXK1 and TMEM245 were positive and significant. FOXK1‑knockdown led to decreased miR‑32 and TMEM245 expression and increased PTEN expression, whereas FOXK1‑overexpression had the opposite effect. Overexpressed FOXK1 promoted the malignancy of CRC cells in vitro by stimulating proliferation and reducing apoptosis; whereas FOXK1‑depletion suppressed such malignancy and a miR‑32 inhibitor partially reversed the effects of FOXK1. The results of ChIP and dual‑luciferase reporter assays indicated that FOXK1 directly binds to the promoter of TMEM245/miR‑32. Thus, the FOXK1‑miR‑32‑PTEN signaling axis may play a crucial role in the pathogenesis and development of CRC.